Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • March4NETs
NET Nurse
Donate

Home » Research » 46th Annual Clinical Oncology Society of Australia (COSA) Meeting

46th Annual Clinical Oncology Society of Australia (COSA) Meeting

  • November 28, 2019

COSA held its 46th ASM in Adelaide 12 – 14 November 2019. There was an excellent attendance of multidisciplinary practitioners at the conference which was themed “Putting Precision and Personalisation into Practice”. COSA membership is diverse and the ASM celebrates this diversity with the depth of presentations by Clinicians, Researchers, Nurse, Pharmacists and Allied Health Professionals. There was a strong focus on Digital Technology to ensure comprehensive collection and utilization of data and also the impact of distance for cancer care. Another session was in the form of an MDT case discussion titled “A couple armed with an iPad” which covered gender issues, couples, sexuality, age and medicinal cannabis.

The Unicorn Foundation team attended the ASM. Over the three days there were sessions entitled “The Best of the Orals”, which saw the presented abstracts which had been submitted. Our CEO Simone, presented one of our current projects which is “Assessing the gaps in experience and knowledge of Australian Primary Health Care Professionals (GPs) in treating and caring for the increasing number of neuroendocrine tumour (NET) patients“. In this same session there was a presentation about – “Facilitating effective family carer engagement in cancer care – Development of education modules”.

On the final day the Plenary session was “Personalising cancer care at the population level: Beyond age and gender”. This presentation looked at cancer epidemiology across age spectrums (incidence, prevalence, burden and issues of disease, What about Race?, the emergence of youth cancer as a unique model of care and older cancer patients – the evolution of geriatric oncology and palliative care). Again this session was very thought provoking, taking into account the diversity of cancer patients and their needs. In the afternoon we had the privilege of an intimate Q&A and a performance by Kirk Pengilly (INXS band member) who talked about his cancer experience.

Meetings such as this ASM, are forums for updating and gaining knowledge of research and improvements in care. It also is a time to meet with International speakers and national colleagues to collaborate and share our work and plan for the future of cancer care.

Report by Meredith Cummins (UF Project Officer)

Share this post

Recent posts

BioPharmaDispatch 2025: Putting NETs on the National Agenda

May 27, 2025

WA Cancer Forum

May 27, 2025

ANZSNM 55th annual conference in Melbourne – Australia

May 27, 2025

NECA Strategy Day 2025

May 27, 2025
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousClinical Trials and Neuroendocrine Tumours
NextNeuroEndocrine Cancer Australia present 6 scientific abstracts at ENETs 2020Next

Related Posts

NECA at ENETS 2025: Advancing NET Care on the Global Stage

NeuroEndocrine Cancer Australia at ENETS 2025: Advancing NET Care on the Global Stage NeuroEndocrine Cancer Australia (NECA) proudly represented Australia at the 22nd Annual European

The Australian Cancer Plan

Shaping the future of cancer control together   We are pleased to send you this update on the Australian Cancer Plan, the first national 10-year

Impact of Nutritional Status on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) Aggressiveness

Read full report

Peter MacCallum Cancer Centre – Recruiting NET health professionals for International Delphi survey

Recruiting NET health professionals for International Delphi survey Development of a neuroendocrine tumour (NET) nutrition-risk screening tool to identify patients requiring nutrition intervention and education

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2025 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin